The objective of the course is to provide the scientific community with experts in the fields of medical biotechnology and molecular medicine able to develop new experimental models for the study of human diseases, to develop new diagnostic approaches, to identify new therapeutic molecules, to devise innovative drug delivery systems. All these possibilities arise from the competences of the Master?s graduate who will have a strong medical educational background that will allow her/him to represent a fruitful interface with the clinics, building a bridge between the bench and the bedside. A deep knowledge of the pathogenetic mechanisms of diseases is required in order to apply basic disciplines to the resolution of medical problems.
Employment opportunities: public and private research structures, including Universities, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health); Hospitals; private pharmaceutical, diagnostics and biotechnological companies; companies supporting scientific research (instruments, biotechnological reagents); companies involved in science communication and publishing.
Below a list of professional profiles:
Medical Science Liaison (MSL) within pharmaceutical and biotechnological companies
In the pharmaceutical and biotechnological companies, this new professional figure has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company.This professional has a strong medical and pharmacological background that enable her/him to talk with physicians in order to solve clinical problem related to the use of specific drugs.
Clinical Monitor within pharmaceutical and biotechnological companies; CRO (Clinical Research Organization) (upon completion of a specific training course)
Thanks to the strong background in pharmacology and statistics this expert will be able to coordinate clinical studies.
Market Access Manager within pharmaceutical and biotechnological companies; consulting agencies, AIFA (Italian agency for drugs) (upon completion of a specific training course)
Thanks to the strong background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs, the graduate will be in the ideal position to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products.
Medical and scientific communication advisor within scientific and medical communication agencies and publishers
Thanks to the multidisciplinary approaches to medical sciences acquired during the course, the Master Programme? graduate may evolve into a medical writer or a consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education or again as an advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
The graduates in the Master Program in Medical Biotechnology and Molecular Medicine will have access to PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).Employment statistics (Almalaurea)